BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 31696473)

  • 21. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
    Lu W; Xu Z; Zhang M; Zuo Y
    Int J Clin Exp Pathol; 2014; 7(10):7286-96. PubMed ID: 25400827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-489 targets XIAP to inhibit the biological progression of ovarian cancer via regulating PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.
    Jiang HW; Li L; Jiang P; Wang YF
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4113-4122. PubMed ID: 32373947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-28 promotes cell proliferation and invasion in gastric cancer via the PTEN/PI3K/AKT signalling pathway.
    Li L; Zhu X; Shou T; Yang L; Cheng X; Wang J; Deng L; Zheng Y
    Mol Med Rep; 2018 Mar; 17(3):4003-4010. PubMed ID: 29257342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-107 regulates growth and metastasis of gastric cancer cells via activation of the PI3K-AKT signaling pathway by down-regulating FAT4.
    Wang L; Li K; Wang C; Shi X; Yang H
    Cancer Med; 2019 Sep; 8(11):5264-5273. PubMed ID: 31297980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
    He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
    Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-218 inhibits gastric tumorigenesis through regulating Bmi-1/Akt signaling pathway.
    Wu Y; Tian S; Chen Y; Ji M; Qu Y; Hou P
    Pathol Res Pract; 2019 Feb; 215(2):243-250. PubMed ID: 30420101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
    Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q
    J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CircRNA_0005075 suppresses carcinogenesis via regulating miR-431/p53/epithelial-mesenchymal transition axis in gastric cancer.
    Wu J; Chen Z; Song Y; Zhu Y; Dou G; Shen X; Zhou Y; Jiang H; Li J; Peng Y
    Cell Biochem Funct; 2020 Oct; 38(7):932-942. PubMed ID: 32133664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-484 suppressed proliferation, migration, invasion and induced apoptosis of gastric cancer via targeting CCL-18.
    Liu J; Li SM
    Int J Exp Pathol; 2020 Dec; 101(6):203-214. PubMed ID: 32985776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-589 promotes gastric cancer aggressiveness by a LIFR-PI3K/AKT-c-Jun regulatory feedback loop.
    Zhang F; Li K; Pan M; Li W; Wu J; Li M; Zhao L; Wang H
    J Exp Clin Cancer Res; 2018 Jul; 37(1):152. PubMed ID: 30012200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
    Li YM; Li XJ; Yang HL; Zhang YB; Li JC
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2.
    Wang XF; Shi ZM; Wang XR; Cao L; Wang YY; Zhang JX; Yin Y; Luo H; Kang CS; Liu N; Jiang T; You YP
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):573-84. PubMed ID: 22207524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The SNAIL/miR-128 axis regulated growth, invasion, metastasis, and epithelial-to-mesenchymal transition of gastric cancer.
    Yu WW; Jiang H; Zhang CT; Peng Y
    Oncotarget; 2017 Jun; 8(24):39280-39295. PubMed ID: 28424413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-936/ERBB4/Akt axis exhibits anticancer properties of gastric cancer through inhibition of cell proliferation, migration, and invasion.
    Liu S; Gong Y; Xu XD; Shen H; Gao S; Bao HD; Guo SB; Yu XF; Gong J
    Kaohsiung J Med Sci; 2021 Feb; 37(2):111-120. PubMed ID: 33021020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
    He C; Wang L; Zhang J; Xu H
    Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-760 inhibits the biological progression of colorectal carcinoma by directly targeting FOXA1 and regulating epithelial-to-mesenchymal transition and PI3K/AKT signaling pathway.
    Cong K; Li CG; Wei YH; Zhang K; Xu HB
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5730-5740. PubMed ID: 31298352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-1-3p suppresses cell proliferation and invasion and targets STC2 in gastric cancer.
    Ke J; Zhang BH; Li YY; Zhong M; Ma W; Xue H; Wen YD; Cai YD
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8870-8877. PubMed ID: 31696489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The molecular mechanism of baicalein repressing progression of gastric cancer mediating miR-7/FAK/AKT signaling pathway.
    Qiao D; Xing J; Duan Y; Wang S; Yao G; Zhang S; Jin J; Lin Z; Chen L; Piao Y
    Phytomedicine; 2022 Jun; 100():154046. PubMed ID: 35306368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting EZH2 by microRNA-449a inhibits osteosarcoma cell proliferation, invasion and migration via regulation of PI3K/AKT signaling pathway and epithelial-mesenchymal transition.
    Lu DG; Tang QL; Wei JH; He FY; Lu L; Tang YJ
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1656-1665. PubMed ID: 32141531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.